312 related articles for article (PubMed ID: 14719993)
1. Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.
Roomans GM
Am J Respir Med; 2003; 2(5):413-31. PubMed ID: 14719993
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological treatment of the ion transport defect in cystic fibrosis.
Roomans GM
Expert Opin Investig Drugs; 2001 Jan; 10(1):1-19. PubMed ID: 11116277
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of the ion transport defect in cystic fibrosis: role of purinergic receptor agonists and other potential therapeutics.
Kunzelmann K; Mall M
Am J Respir Med; 2003; 2(4):299-309. PubMed ID: 14719996
[TBL] [Abstract][Full Text] [Related]
4. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX.
Andersson C; Roomans GM
Eur Respir J; 2000 May; 15(5):937-41. PubMed ID: 10853862
[TBL] [Abstract][Full Text] [Related]
5. New horizons in the treatment of cystic fibrosis.
Cuthbert AW
Br J Pharmacol; 2011 May; 163(1):173-83. PubMed ID: 21108631
[TBL] [Abstract][Full Text] [Related]
6. Novel Approaches for Potential Therapy of Cystic Fibrosis.
Sawczak V; Getsy P; Zaidi A; Sun F; Zaman K; Gaston B
Curr Drug Targets; 2015; 16(9):923-36. PubMed ID: 25557257
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
Knowles MR; Olivier K; Noone P; Boucher RC
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
[TBL] [Abstract][Full Text] [Related]
8. Targeting ion channels in cystic fibrosis.
Mall MA; Galietta LJ
J Cyst Fibros; 2015 Sep; 14(5):561-70. PubMed ID: 26115565
[TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of the ion transport defect in cystic fibrosis.
Kunzelmann K; Mall M
Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):857-67. PubMed ID: 11703384
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
11. Activation of chloride transport in CF airway epithelial cell lines and primary CF nasal epithelial cells by S-nitrosoglutathione.
Servetnyk Z; Krjukova J; Gaston B; Zaman K; Hjelte L; Roomans GM; Dragomir A
Respir Res; 2006 Oct; 7(1):124. PubMed ID: 17022806
[TBL] [Abstract][Full Text] [Related]
12. Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospects.
Kuk K; Taylor-Cousar JL
Ther Adv Respir Dis; 2015 Dec; 9(6):313-26. PubMed ID: 26416827
[TBL] [Abstract][Full Text] [Related]
13. Functions of the cystic fibrosis transmembrane conductance regulator protein.
Frizzell RA
Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S54-8. PubMed ID: 7533606
[TBL] [Abstract][Full Text] [Related]
14. Can correcting the ΔF508-CFTR proteostasis-defect rescue CF lung disease?
Valle CW; Vij N
Curr Mol Med; 2012 Aug; 12(7):860-71. PubMed ID: 22697346
[TBL] [Abstract][Full Text] [Related]
15. CFTR: folding, misfolding and correcting the ΔF508 conformational defect.
Lukacs GL; Verkman AS
Trends Mol Med; 2012 Feb; 18(2):81-91. PubMed ID: 22138491
[TBL] [Abstract][Full Text] [Related]
16. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
[TBL] [Abstract][Full Text] [Related]
17. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
[TBL] [Abstract][Full Text] [Related]
18. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
[TBL] [Abstract][Full Text] [Related]
19. Effect of genistein on native epithelial tissue from normal individuals and CF patients and on ion channels expressed in Xenopus oocytes.
Mall M; Wissner A; Seydewitz HH; Hübner M; Kuehr J; Brandis M; Greger R; Kunzelmann K
Br J Pharmacol; 2000 Aug; 130(8):1884-92. PubMed ID: 10952679
[TBL] [Abstract][Full Text] [Related]
20. Protein processing and inflammatory signaling in Cystic Fibrosis: challenges and therapeutic strategies.
Belcher CN; Vij N
Curr Mol Med; 2010 Feb; 10(1):82-94. PubMed ID: 20205681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
